188 related articles for article (PubMed ID: 14770276)
1. Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor.
Wejksza K; Rzeski W; Parada-Turska J; Zdzisinska B; Rejdak R; Kocki T; Okuno E; Kandefer-Szerszen M; Zrenner E; Turski WA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Mar; 369(3):300-4. PubMed ID: 14770276
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93).
Wejksza K; Rzeski W; Okuno E; Kandefer-Szerszen M; Albrecht J; Turski WA
Neurochem Res; 2005 Aug; 30(8):963-8. PubMed ID: 16258845
[TBL] [Abstract][Full Text] [Related]
3. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
4. Effect of pesticides on kynurenic acid production in rat brain slices.
Zielińska E; Kocki T; Saran T; Borbely S; Kuc D; Vilagi I; Urbańska EM; Turski WA
Ann Agric Environ Med; 2005; 12(2):177-9. PubMed ID: 16457470
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells.
Wejksza K; Rzeski W; Turski WA
Pharmacol Rep; 2009; 61(4):751-6. PubMed ID: 19815960
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid.
Stazka J; Luchowski P; Urbanska EM
Eur J Pharmacol; 2005 Jul; 517(3):217-23. PubMed ID: 15961072
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons.
Rzeski W; Kocki T; Dybel A; Wejksza K; Zdzisińska B; Kandefer-Szerszeń M; Turski WA; Okuno E; Albrecht J
J Neurosci Res; 2005 Jun; 80(5):677-82. PubMed ID: 15880762
[TBL] [Abstract][Full Text] [Related]
8. Kynurenate production by cultured human astrocytes.
Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
Bortz DM; Wu HQ; Schwarcz R; Bruno JP
Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
[TBL] [Abstract][Full Text] [Related]
10. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II.
Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM
Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557
[TBL] [Abstract][Full Text] [Related]
11. Formation of endogenous glutamatergic receptors antagonist kynurenic acid--differences between cortical and spinal cord slices.
Urbańska EM; Chmielewski M; Kocki T; Turski WA
Brain Res; 2000 Sep; 878(1-2):210-2. PubMed ID: 10996154
[TBL] [Abstract][Full Text] [Related]
12. Cysteine and keto acids modulate mosquito kynurenine aminotransferase catalyzed kynurenic acid production.
Han Q; Li J
FEBS Lett; 2004 Nov; 577(3):381-5. PubMed ID: 15556614
[TBL] [Abstract][Full Text] [Related]
13. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling.
Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240
[TBL] [Abstract][Full Text] [Related]
14. Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists.
Zarnowski T; Bialek M; Rejdak R; Zrenner E; Junemann A; Zagorski Z; Kocki T; Turski WA
J Neural Transm (Vienna); 2006 Oct; 113(10):1367-72. PubMed ID: 16465462
[TBL] [Abstract][Full Text] [Related]
15. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
[TBL] [Abstract][Full Text] [Related]
16. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
17. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro.
Zakrocka I; Turski WA; Kocki T
Eur J Pharmacol; 2016 Oct; 789():308-312. PubMed ID: 27423316
[TBL] [Abstract][Full Text] [Related]
19. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.
Baran H; Cairns N; Lubec B; Lubec G
Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415
[TBL] [Abstract][Full Text] [Related]
20. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
